Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy

被引:43
|
作者
Hosokawa, Takanori [1 ]
Kurosaki, Masayuki [1 ]
Tsuchiya, Kaoru [1 ]
Matsuda, Shuya [1 ]
Muraoka, Masaru [1 ]
Suzuki, Yuichiro [1 ]
Tamaki, Nobuharu [1 ]
Yasui, Yutaka [1 ]
Nakata, Toru [1 ]
Nishimura, Takashi [1 ]
Suzuki, Shoko [1 ]
Ueda, Ken [1 ]
Nakanishi, Hiroyuki [1 ]
Itakura, Jun [1 ]
Takahashi, Yuka [1 ]
Izumi, Namiki [1 ]
机构
[1] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Musashino, Tokyo 1808610, Japan
关键词
Hyperglycemia; Hepatocellular carcinoma; Recurrence; Radio frequency ablation; Survival; BREAST-CANCER CELLS; DIABETES-MELLITUS; RADIOFREQUENCY ABLATION; DISTANT RECURRENCE; RISK-FACTORS; HEPATITIS; TYPE-2; METAANALYSIS; CONSENSUS; IMPACT;
D O I
10.3748/wjg.v19.i2.249
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate whether metabolic factors are related to distant recurrence of hepatocellular carcinoma (HCC) and survival after curative treatment. METHODS: This retrospective study included 344 patients whose HCC was treated curatively by radio-frequency ablation (RFA) therapy. The mean age was 67.6 years and the mean observation period was 4.04 years. The etiological background of liver disease was hepatitis B virus infection in 30, hepatitis C virus infection in 278, excessive alcohol drinking in 9, and other in 27 patients. The Child-Pugh classification grade was A (n = 307) or B (n = 37). The number of HCC nodules was one in 260, two in 61, and three in 23 patients. For surveillance of HCC recurrence after curative therapy with RFA, patients were radiologically evaluated every 3 mo. Factors associated with distant recurrence of HCC or survival were studied. RESULTS: Inadequate maintenance of blood glucose in diabetic patients was associated with higher incidence of distant recurrence. The 1-, 2-, and 3-year recurrence rates were significantly higher in diabetic patients with inadequate maintenance of blood glucose compared with the others: 50.6% vs 26.8%, 83.5% vs 54.4%, and 93.8% vs 73.0%, respectively (P = 0.0001). Inadequate maintenance of blood glucose was an independent predictor of distant recurrence [adjusted relative risk 1.97 (95% CI, 1.33-2.91), (P = 0.0007)] after adjustment for other risk factors, such as number of HCC nodules [2.03 (95% CI, 1.51-2.73), P < 0.0001] and initial level of serum alpha fetoprotein (AFP) [1.43 (95% CI, 1.04-1.97), P = 0.028]. Obesity was not an independent predictor of recurrence. The incidence of distant recurrence did not differ between diabetic patients with adequate maintenance of blood glucose and non-diabetic patients. Among 232 patients who had HCC recurrence, 138 had a second recurrence. The 1-, 2-, and 3-year rates of second recurrence were significantly higher in diabetic patients with inadequate maintenance of blood glucose than in the others: 9.0% vs 5.9%, 53.1% vs 24.3%, and 69.6% vs 42.3%, respectively (P = 0.0021). Inadequate maintenance of blood glucose in diabetic patients [1.99 (95% CI, 1.23-3.22), P = 0.0049] and presence of multiple HCC nodules [1.53 (95% CI, 1.06-2.22), P = 0.024] were again significantly associated with second HCC recurrence. Inadequate maintenance of blood glucose in diabetic patients was also a significant predictor of poor survival [2.77 (95% CI, 1.38-5.57), P = 0.0046] independent of excessive alcohol drinking [6.34 (95% CI, 1.35-29.7), P = 0.019], initial level of serum AFP [3.40 (95% CI, 1.88-6.18), P < 0.0001] and Child-Pugh classification grade B [2.24 (95% CI, 1.12-4.46), P = 0.022]. Comparing diabetic patients with inadequate maintenance of blood glucose vs the others, the 1-, 2-, and 3-year survival rates were significantly lower in diabetic patients with inadequate maintenance of blood glucose: 92% vs 99%, 85% vs 96%, and 70% vs 92%, respectively (P = 0.0003). CONCLUSION: Inadequate maintenance of blood glucose in diabetic patients is a significant risk factor for recurrence of HCC and for poor survival after curative RFA therapy. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 50 条
  • [21] Prognostic factors after curative resection hepatocellular carcinoma and the surgeon's role
    You, Dong Do
    Kim, Dong Goo
    Seo, Chang Ho
    Choi, Ho Joong
    Yoo, Young Kyung
    Park, Yong Gyu
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2017, 93 (05) : 252 - 259
  • [22] Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment
    Kamachi, Saori
    Mizuta, Toshihiko
    Otsuka, Taiga
    Nakashita, Shunya
    Ide, Yasushi
    Miyoshi, Atsushi
    Kitahara, Kenji
    Eguchi, Yuichiro
    Ozaki, Iwata
    Anzai, Keizo
    HEPATOLOGY RESEARCH, 2016, 46 (02) : 201 - 208
  • [23] An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy
    Tokumitsu, Yukio
    Tamesa, Takao
    Matsukuma, Satoshi
    Hashimoto, Noriaki
    Maeda, Yoshinari
    Tokuhisa, Yoshihiro
    Sakamoto, Kazuhiko
    Ueno, Tomio
    Hazama, Shoichi
    Ogihara, Hiroyuki
    Fujita, Yusuke
    Hamamoto, Yoshihiko
    Oka, Masaaki
    Iizuka, Norio
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (03) : 944 - 952
  • [24] Lipoprotein (a): a promising prognostic biomarker in patients with hepatocellular carcinoma after curative resection
    Gao, Xing-hui
    Zhang, Shuang-shuang
    Chen, Hao
    Wang, Kun
    Xie, Wen
    Wang, Fu-Bing
    ONCOTARGETS AND THERAPY, 2018, 11 : 5917 - 5924
  • [25] Adjuvant Therapy for Hepatocellular Carcinoma after Curative Treatment
    Jeng, Wen-Juei
    Lin, Chen-Chun
    Chen, Wei-Ting
    Sheen, I-Shyan
    Lin, Chun-Yen
    Lin, Shi-Ming
    DIGESTIVE DISEASES, 2014, 32 (06) : 747 - 754
  • [26] Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments:a meta-analysis
    Wei-Min Wang
    Key Laboratory of Carcinogenesis and Cancer Invasion
    Fudan University Shanghai Cancer Center
    Hepatobiliary & Pancreatic Diseases International, 2011, 10 (04) : 346 - 355
  • [27] Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
    Farinati, Fabio
    Sergio, Adriana
    Giacomin, Anna
    Di Nolfo, Maria Anna
    Del Poggio, Paolo
    Benvegnu, Luisa
    Rapaccini, Gianludovico
    Zoli, Marco
    Borzio, Franco
    Giannini, Edoardo G.
    Caturelli, Eugenio
    Trevisani, Franco
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (10) : 1212 - 1218
  • [28] Antiviral therapy after curative treatment of hepatocellular carcinoma in patients with chronic hepatitis B infection: Is tenofovir or entecavir preferred?
    van Erpecum, Karel J.
    Sonneveld, Milan J.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 27 - 29
  • [29] The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma
    Chuma, Makoto
    Hige, Shuhei
    Kamiyama, Toshiya
    Meguro, Takashi
    Nagasaka, Atsushi
    Nakanishi, Kazuaki
    Yamamoto, Yoshiya
    Nakanishi, Mitsuru
    Kohara, Toshihisa
    Sho, Takuya
    Yamamoto, Keiko
    Horimoto, Hiromasa
    Kobayashi, Tomoe
    Yokoo, Hideki
    Matsushita, Michiaki
    Todo, Satoru
    Asaka, Masahiro
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (09) : 991 - 999
  • [30] Prognostic value of postoperative complication for early recurrence after curative resection of hepatocellular carcinoma
    Amisaki, Masataka
    Saito, Hiroaki
    Tokuyasu, Naruo
    Sakamoto, Teruhisa
    Honjo, Soichiro
    Fujiwara, Yoshiyuki
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (04) : 323 - 329